Manu Ohri Net Worth & Insider Trades

Manu Ohri - CFO & Secretary, GT Biopharma, Inc

As of August 15, 2023

What is Manu Ohri's Net Worth?

The current estimated net worth of GT Biopharma, Inc's CFO & Secretary, Manu Ohri, is estimated to be about $65K . Manu Ohri owns about 150,000 units of GT Biopharma, Inc common stock. In the last year at GT Biopharma, Inc, Manu Ohri has sold an estimated value of $57.4K worth.

What is Manu Ohri's Past Insider Trading?

Manu Ohri's largest purchase order was 50,000 units , worth over $25K on April 10, 2023. In total, Manu Ohri has made about 4 transactions over a year of their time at GT Biopharma, Inc. Manu Ohri usually trades in April, August, February and July, with the busiest year in 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Manu Ohri

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Manu Ohri's' Mailing Address?

  • Mailing address is 2355 Main Street Suite 120 Irvine CA 92614 CA

What are GT Biopharma, Inc's Past Insider Trades?

GT Biopharma, Inc's most recent insider trade came on April 11, 2023 by Michael Martin Breen who bought 50,000 units worth $25K . In the last 4 years, insiders at GT Biopharma, Inc have sold an estimated value of $301.64K and bought an estimated value of $418.85K worth of shares. Insider trading is most common in February, with the busiest year in 2023 and 2022. The most active traders at the company are Steven Weldon,  Michael Martin Breen, Executive Chairman/Interim CEO,  and Manu Ohri, CFO & Secretary .

GT Biopharma, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...